Saturday 17 October 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%

Follow LH

Alert me

Market cap: $26.4B
P/E: 26.2×
Fwd P/E: 19.0×
Dividend yield: 0.90%
F-score: 8/9
Altman Z: 3.02
Beneish M: −2.55
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 11.92

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	7	3	—	1	1	2	4	—	—

Insider Ownership 1.14%

Capital & Financial Ratios $m

Market Cap 26,360.00

Revenue 14,348.00

Net Income 1,003.50

Free Cash Flow 1,170.50

Net Debt 5,777.40

Current Ratio 1.80

Debt/Equity 0.69

P/E ratio 26.18

Fwd P/E 19.00

P/S ratio 1.81

P/B ratio 3.02

Past 5Y EPS Growth (8.01%)

This Y EPS Growth 11.63%

Next Y EPS Growth 8.05%

Next Y revenue growth 5.71%

Next 5Y EPS Growth 9.53%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 75.12%

10-year low 10-year high

P/S against its own 10 years 98.75%

10-year low 10-year high

P/B against its own 10 years 98.97%

10-year low 10-year high

EV/Sales against its own 10 years 98.78%

10-year low 10-year high

EV/FCF against its own 10 years 92.66%

10-year low 10-year high

Dividends

Payout Ratio 0.24

Annual Dividend Rate 2.88

Annual Dividend Yield 0.90%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	2.91	0.72 0.72 0.72
2025	2.88	0.72 0.72 0.72 0.72
2024	3.60	0.72 0.72 0.72 0.72 0.72
2023	2.68	0.62 0.62 0.72 0.72
2022	1.86	0.62 0.62 0.62
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	537	1,519	532	142
Receivables	2,099	2,097	2,261	2,505
Inventory	475	493	535	562
Other	—	—	—	—
	3,765	4,807	4,021	3,815

	2023	2024	2025	Q'26
Payables	828	876	841	689
ST’ Debt	—	—	—	—
Other	—	—	—	—
	3,225	3,330	2,824	2,125

Compound Annual Growth %

	10y	5y	3y
Sales	4.86%	(0.04%)	5.55%
Cash Flow	5.26%	(5.14%)	(5.69%)
Earnings	7.19%	(10.85%)	(11.84%)
Book Value	5.71%	(1.79%)	(5.13%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	3,538	3,731	—	—	—
’25	3,345	3,527	3,564	3,516	13,952
’24	3,177	3,221	3,282	3,329	13,009
’23	3,038	3,034	3,057	3,033	12,162
’22	3,900	2,923	2,867	2,175	11,864
’21	4,162	3,841	4,063	1,071	13,136
’20	2,824	2,769	3,896	4,490	13,979

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	192	446	—	—	—
’25	19	621	387	614	1,641
’24	(30)	561	277	777	1,586
’23	121	351	276	580	1,328
’22	356	573	374	654	1,956
’21	1,158	487	767	698	3,110
’20	204	371	786	775	2,135

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	78	316	—	—	—
’25	(107)	545	282	495	1,214
’24	(163)	433	162	667	1,098
’23	43	111	171	413	875
’22	240	442	291	555	1,528
’21	1,065	390	650	670	2,775
’20	104	272	703	716	1,796

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	3.35	3.64	—	—	—
’25	2.52	2.84	3.12	1.98	10.46
’24	2.69	2.43	2.00	1.70	8.84
’23	2.39	2.12	2.11	(1.95)	4.77
’22	5.23	3.87	3.90	0.86	13.97
’21	7.82	4.76	6.05	5.75	24.39
’20	(3.27)	2.37	7.17	9.54	15.88

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	84.01	109.97	102.56	105.04	84.21	172.41	172.10	179.59	191.97	209.38	Analyst estimates 2026–2028 Powerpack
	High	121.41	141.91	163.54	153.30	187.95	272.48	269.75	227.84	247.99	293.72
People
People	Employees	52,000	60,000	61,000	65,000	72,400	75,500	80,000	67,000	70,000	71,000
	Revenue/emp, $m	0.18	0.17	0.19	0.18	0.19	0.17	0.15	0.18	0.19	0.20
Income, $m
Income, $m	Revenue	9,553	10,308	11,333	11,555	13,979	13,136	11,864	12,162	13,009	13,952
	Gross margin, %	29.88	29.99	28.03	28.15	35.43	38.01	31.26	27.67	27.86	28.76
	EBT	1,074	1,078	1,268	1,105	2,219	2,888	1,237	569	960	1,108
	EBT margin, %	11.24	10.45	11.19	9.56	15.88	21.98	10.43	4.68	7.38	7.94
	Net income	713	1,233	884	825	1,557	2,380	1,281	419	747	878
	Depreciation	501	533	552	577	1,087	577	537	577	644	681
Per share, $
Per share, $	Revenue	93.20	100.66	111.77	118.03	143.66	135.84	130.23	139.63	155.05	167.69
	Earnings	7.14	12.39	8.71	8.42	15.99	24.60	14.05	4.80	8.89	10.54
	Cash flow	11.68	14.63	12.87	14.76	21.95	32.16	21.47	15.24	18.90	19.72
	Capex	(2.42)	(3.03)	(3.25)	(4.01)	(3.49)	(3.46)	(4.70)	(5.20)	(5.82)	(5.13)
	Free cash flow	9.26	11.60	9.62	10.75	18.46	28.70	16.77	10.04	13.09	14.59
	Book value	53.72	66.45	68.75	77.29	96.98	106.24	110.83	90.41	95.97	103.60
	Shares, m	103	102	101	98	97	97	91	87	84	83
Valuation, ×
Valuation, ×	P/E	15.73	11.25	12.46	17.26	10.96	10.98	14.66	49.48	25.80	23.80
	P/S	1.19	1.39	0.97	1.23	1.22	1.99	1.57	1.67	1.48	1.50
	P/B	2.06	2.10	1.58	1.88	1.80	2.54	1.84	2.57	2.39	2.42
	EV/Sales	1.70	1.97	1.47	1.77	1.56	2.29	1.97	1.96	1.78	1.83
	EV/FCF	17.10	17.09	17.09	19.44	12.14	10.87	15.35	32.39	24.10	23.69
Cash, $m
Cash, $m	Operating cash flow	1,197	1,498	1,305	1,445	2,135	3,110	1,956	1,328	1,586	1,641
	Capex	(248)	(310)	(330)	(392)	(340)	(334)	(428)	(453)	(488)	(426)
	Free cash flow	949	1,188	976	1,052	1,796	2,775	1,528	875	1,098	1,214
Balance, $m
Balance, $m	Working capital	651	548	957	325	2,047	2,548	1,547	540	1,476	1,197
	Total debt	5,300	6,345	6,042	5,881	5,503	5,501	5,122	4,133	5,406	5,148
	Net debt	4,866	6,028	5,615	5,543	4,183	4,028	4,802	3,597	3,887	4,615
	Shareholders’ equity	5,506	6,804	6,971	7,567	9,437	10,273	10,097	7,875	8,052	8,620
Returns, %
Returns, %	ROA	5.02	7.94	5.38	4.81	8.16	11.75	6.31	2.27	4.25	4.77
	ROIC	7.66	6.36	6.58	6.34	11.22	13.32	6.03	3.95	5.69	6.54
	ROE	13.62	19.94	12.83	11.33	18.30	24.12	12.56	4.65	9.37	10.51

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
WAT Waters Corporation	$43.6B	109×	44.3×	+113.36% (above 0%: growing)	n/m	+750.00% (above 0%: growing)	44.62%	(5.23%)	Compare
IDXX IDEXX Laboratories, Inc.	$43.1B	39.1×	38.3×	+9.66% (above 0%: growing)	+17.21% (above 0%: growing)	+111.44% (above 0%: growing)	64.04%	34.98%	Compare
ILMN Illumina, Inc.	$40.5B	48.4×	34.7×	+9.44% (above 0%: growing)	−8.05% (below 0%: shrinking)	−18.27% (below 0%: shrinking)	66.44%	21.14%	Compare
MTD Mettler-Toledo International, Inc.	$32.8B	36.4×	25.5×	+4.48% (above 0%: growing)	+18.30% (above 0%: growing)	+33.01% (above 0%: growing)	63.29%	30.61%	Compare
DGX Quest Diagnostics Incorporated	$26.4B	24.6×	20.8×	+10.21% (above 0%: growing)	+14.74% (above 0%: growing)	+5.28% (above 0%: growing)	33.75%	15.08%	Compare
LH Labcorp Holdings Inc.	$26.4B	26.2×	19.0×	+5.78% (above 0%: growing)	+28.42% (above 0%: growing)	−42.01% (below 0%: shrinking)	29.80%	12.10%
GH Guardant Health, Inc.	$22.3B	— (loss-making)	— (loss-making)	+44.33% (above 0%: growing)	n/m	−5.46% (below 0%: shrinking)	65.39%	(38.55%)	Compare
MEDP Medpace Holdings, Inc.	$17.6B	35.6×	26.7×	+17.24% (above 0%: growing)	+36.39% (above 0%: growing)	−3.03% (below 0%: shrinking)	71.36%	20.76%	Compare
RVTY Revvity Inc.	$17.3B	72.7×	37.5×	+1.31% (above 0%: growing)	+2.17% (above 0%: growing)	+59.29% (above 0%: growing)	57.13%	12.24%	Compare
Median of peers	$29.6B	39.1×	34.7×	+9.94%	+15.98%	+19.15%	63.66%	17.92%

All 52 Diagnostics & Research stocks →

Labcorp Holdings Inc. (LH) key facts

Strength: Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
Labcorp Holdings Inc. (LH) is a Diagnostics & Research company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, LH traded at $318.66, a market capitalization of $26.4 billion.
Labcorp Holdings Inc. pays an annual dividend of $2.88 per share, a yield of 0.90%, with a payout ratio of 23.8%.
Return on equity was 10.5% and debt-to-equity 0.69.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 3.02 (safe zone) for fiscal 2025.